Literature DB >> 25471004

Unusual treatment of Kasabach-Merritt syndrome secondary to hepatic hemangioma: embolization with bleomycin.

Halil Bozkaya1, Celal Cinar, Ömer Vedat Ünalp, Mustafa Parildar, Ismail Oran.   

Abstract

Kasabach-Merritt syndrome (KMS) is a rare complication of cavernous hemangiomas characterized with anemia, thrombocytopenia, and consumption coagulopathy. This syndrome usually develops due to superficial soft tissue hemangiomas in infancy and childhood. KMS developing secondarily to hepatic hemangioma is very rare. In this report, we aimed to present the treatment of KMS developing secondarily to giant cavernous hemangioma of the liver with transarterial chemoembolization using bleomycin.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25471004     DOI： 10.1007/s00508-014-0675-5

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN： 0043-5325            Impact factor:   1.704


  8 in total

Review 1.  Kasabach-Merritt syndrome: pathogenesis and management.

Authors:  G W Hall
Journal:  Br J Haematol       Date:  2001-03       Impact factor: 6.998

2.  Gigantic cavernous hemangioma of the liver treated by intra-arterial embolization with pingyangmycin-lipiodol emulsion: a multi-center study.

Authors:  Qingle Zeng; Yanhao Li; Yong Chen; Yong Ouyang; Xiang He; Heping Zhang
Journal:  Cardiovasc Intervent Radiol       Date:  2004-07-30       Impact factor: 2.740

3.  Transcatheter arterial embolization of two symptomatic giant cavernous hemangiomas of the liver.

Authors:  S Althaus; B Ashdown; D Coldwell; W S Helton; P C Freeny
Journal:  Cardiovasc Intervent Radiol       Date:  1996 Sep-Oct       Impact factor: 2.740

4.  Treatment of Kasabach-Merritt syndrome by embolisation of a giant liver hemangioma.

Authors:  A Billio; N Pescosta; C Rosanelli; G F Zanon; P G Gamba; S Savastano; P Coser
Journal:  Am J Hematol       Date:  2001-02       Impact factor: 10.047

5.  Surgical management of giant hepatic hemangiomas: complications and review of the literature.

Authors:  Hui-Yu Ho; Tsung-Han Wu; Ming-Chin Yu; Wei-Chen Lee; Tzu-Chieh Chao; Miin-Fu Chen
Journal:  Chang Gung Med J       Date:  2012 Jan-Feb

Review 6.  Preoperative transcatheter arterial embolization for giant cavernous hemangioma of the liver with consumption coagulopathy.

Authors:  H Suzuki; Y Nimura; J Kamiya; S Kondo; M Nagino; M Kanai; M Miyachi
Journal:  Am J Gastroenterol       Date:  1997-04       Impact factor: 10.864

7.  [Kasabach-Merritt syndrome in giant hemangioma of the liver. A case report].

Authors:  T Vogel; B Lammers; A von Herbay; B M E Kunz; A J Donner; G Fürst; P E Goretzki
Journal:  Chirurg       Date:  2002-07       Impact factor: 0.955

8.  Transarterial embolization of giant liver hemangiomas associated with Kasabach-Merritt syndrome: a case report.

Authors:  K Malagari; E Alexopoulou; S Dourakis; A Kelekis; K Hatzimichail; A Sissopoulos; S Delis; D Letsou; D Kelekis
Journal:  Acta Radiol       Date:  2007-07       Impact factor: 1.990
  8 in total
  3 in total

1.  Effectiveness of Transarterial Embolization in Treatment of Symptomatic Hepatic Hemangiomas: Systematic Review and Meta-analysis.

Authors:  Pooya Torkian; Jianjun Li; John A Kaufman; Younes Jahangiri
Journal:  Cardiovasc Intervent Radiol       Date:  2020-08-17       Impact factor: 2.740

2.  Prevalence and Characteristics of Hepatic Hemangioma Associated with Coagulopathy and Its Predictive Risk Factors.

Authors:  Shigeo Maruyama; Tomomitsu Matono; Masahiko Koda
Journal:  J Clin Med       Date:  2022-07-26       Impact factor: 4.964

Review 3.  Giant liver hemangioma with adult Kasabach-Merritt syndrome: Case report and literature review.

Authors:  Xiaolei Liu; Zhiying Yang; Haidong Tan; Li Xu; Yongliang Sun; Shuang Si; Liguo Liu; Wenying Zhou; Jia Huang
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.